NCT04532840

Brief Summary

Purpose of the study: The purpose of the study is to evaluate the therapeutic effect of cryotherpy in treating hypertrophic scar. It will be hypothesized that: Cryotherapy may not have an effect on hypertrophic scar.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Apr 2019

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2019

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

August 18, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 31, 2020

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2020

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

August 31, 2020

Status Verified

August 1, 2020

Enrollment Period

1.4 years

First QC Date

August 18, 2020

Last Update Submit

August 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • scar height

    The potential of cryotherapy application in vitro data indicated that using freezing treatment on scar decrease its height

    3 months

Study Arms (2)

Group A: (control group)

ACTIVE COMPARATOR

This group includes 30 patients will receive routine medical treatment and routine physical therapy as (Exercising, Positioning and splinting, Pressure Therapy and Massage).

Other: Exercising, Positioning and splinting, Pressure Therapy and Massage

Group B: (Study group)

EXPERIMENTAL

This group includes 30 patients will receive cryotherapy (at least 10 minutes at -14 degree , 2 sessions per week , for 10 weeks ) in addition to routine medical and physical therapy treatment.

Device: cryotherapy (Gymna Cryoflow ICE-CT)Other: Exercising, Positioning and splinting, Pressure Therapy and Massage

Interventions

Cryotherapy (also called cryoablation) method was produced by James Arnot in England in 1945 to reduce the size of cancerous cells based on the theory that cold blood cells destroy the cells. Campbell White of New York City used cryotherapy as the first dermatological indication in early-stage epithelioma patients in 1890. Later in 1907, Whitehouse described the use of this method in diferent diseases such as pigmented nevus and lupus. In addition, he has published a case series of skin cancers in different face regions.

Also known as: Gymna Cryoflow ICE-CT
Group B: (Study group)

Exercising, Positioning and splinting, Pressure Therapy and Massage

Group A: (control group)Group B: (Study group)

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age range between 20- 40 years.
  • Both sexes will participate in the study.
  • All patients participated will begin treatment program one month after injury depending on injury characteristics.
  • All patients enrolled to the study will have their informed consent.

You may not qualify if:

  • Diabetes mellitus.
  • Individuals with cardiopulmonary conditions.
  • Individuals undergoing radiation therapy or chemotherapy.
  • Hepatic or pancreatic diseases.
  • Sensory impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy

Cairo, Egypt

Location

Related Publications (2)

  • Arno AI, Gauglitz GG, Barret JP, Jeschke MG. Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns. 2014 Nov;40(7):1255-66. doi: 10.1016/j.burns.2014.02.011. Epub 2014 Apr 24.

    PMID: 24767715BACKGROUND
  • Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing--review of the literature. Burns. 2005 Dec;31(8):944-56. doi: 10.1016/j.burns.2005.08.023. Epub 2005 Nov 4.

    PMID: 16274932BACKGROUND

MeSH Terms

Conditions

Cicatrix, Hypertrophic

Interventions

CryotherapyPatient PositioningMassage

Condition Hierarchy (Ancestors)

CicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsPatient CareHealth ServicesHealth Care Facilities Workforce and ServicesTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will be delimited in the following aspects: 1. Subjects: Sixty patients suffering from hypertrophic scar will be randomly divided into two equal groups each one has 30 patients. 2. Equipment and tools: 2.1. Measurement equipment: Vancouver scar scale. MAPS (Matching Assessment of Scars and Photographs) (Masters et al., 2006). 2.2. Therapeutic equipment: Gymna Cryoflow ICE-CT. Temperature resistant polymide tape (48 wide)
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Physical Therapy for Surgery Faculty of Physical Therapy

Study Record Dates

First Submitted

August 18, 2020

First Posted

August 31, 2020

Study Start

April 15, 2019

Primary Completion

September 15, 2020

Study Completion

October 1, 2020

Last Updated

August 31, 2020

Record last verified: 2020-08

Locations